These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2312684)

  • 1. Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolates.
    Aldridge KE; Henderberg A; Schiro DD; Sanders CV
    J Clin Microbiol; 1990 Feb; 28(2):375-8. PubMed ID: 2312684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the E test (PDM epsilometer) and broth microdilution susceptibility tests for members of the Bacteroides fragilis group.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1991; 14(6):501-5. PubMed ID: 1802537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
    Jorgensen JH; Redding JS; Howell AW
    J Clin Microbiol; 1986 Mar; 23(3):545-50. PubMed ID: 3514661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.
    Zabransky RJ; Birk RJ; Kurzynski TA; Toohey KL
    J Clin Microbiol; 1986 Aug; 24(2):181-5. PubMed ID: 3745418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major methodology-dependent discordant susceptibility results for Bacteroides fragilis group isolates but not other anaerobes.
    Aldridge KE; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):135-42. PubMed ID: 7874880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
    Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
    Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
    Aldridge KE; Sanders CV
    J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.
    Aldridge KE; Wexler HM; Sanders CV; Finegold SM
    Antimicrob Agents Chemother; 1990 Jan; 34(1):179-81. PubMed ID: 2327757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
    Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN; Barry AL; Fuchs PC; Allen SD
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
    Hecht DW; Lederer L; Osmolski JR
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
    Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
    Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Rev Infect Dis; 1984; 6 Suppl 1():S242-8. PubMed ID: 6372033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group.
    Zar FA
    Antimicrob Agents Chemother; 1983 Jun; 23(6):947-9. PubMed ID: 6614896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.
    Horn R; Lavallée J; Robson HG
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2051-3. PubMed ID: 1416899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM; Lamothe F; Hoban DJ; Dalton MT; Kibsey PC; Harding G; Smith JA; Low DE; Gilbert H
    Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.